365.63 0.00 (0.00%)
After hours: 6:55PM EST
|Bid||356.00 x 1000|
|Ask||357.40 x 800|
|Day's Range||362.89 - 373.09|
|52 Week Range||271.37 - 442.00|
|Beta (3Y Monthly)||1.19|
|PE Ratio (TTM)||19.56|
|Earnings Date||Feb 4, 2020 - Feb 10, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||386.82|
Dow Jones futures: The stock market rally and Apple stock await China trade war clarity from President Trump on Dec. 15 tariffs. MongoDB, Stitch Fix, Boeing were movers overnight.
Regeneron (REGN) reports initial data for REGN5458, a BCMAxCD3 bispecific antibody, in patients with relapsed or refractory (R/R) multiple myeloma.
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced initial clinical data for REGN5458, a BCMAxCD3 bispecific antibody, in patients with relapsed or refractory (R/R) multiple myeloma. BCMA (B-cell maturation antigen) is a protein that is typically over-expressed on multiple myeloma cells. REGN5458 is designed to bind to BCMA on multiple myeloma cells and the CD3 receptor on T-cells, bridging them together and activating T-cell killing of the cancer cell.
Biotech stocks went back and forth but managed to end the week with a gain. As usual, some stocks swung wildly in reaction to catalysts, primarily clinical readouts. Aurinia Pharmaceuticals Inc (NASDAQ: ...
Results from initial 6-patient cohort show pozelimab reduced lactate dehydrogenase (LDH) to normal levels at week 8 in patients with paroxysmal nocturnal hemoglobinuria (PNH), utilizing a weekly subcutaneous dosing regimen
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and successful investors' positions as of the end of the third quarter. You can find articles about an individual hedge fund's trades on numerous financial […]
With the 2010s officially drawing to a close, Yahoo Finance took a look at some of the biggest S&P 500 winners and losers of the past decade based on price returns.
Regeneron Pharmaceuticals was upgraded to a 'Buy' recommendation today by TheStreet.com's quantitative service. Let's check and see if the technical approach and the quantitative approach are on the same page. Trading volume increased nicely in November and that is a positive sign for chart watchers - rising prices and rising volume.
Alnylam (ALNY) gets FDA approval for givosiran injection for subcutaneous use to treat adults with acute hepatic porphyria. Givosiran injection will be marketed by the trade name of Givlaari.
Authorities released a new list of medicines that China’s government health system will pay for. The prices are significantly below U.S. and international norms.
Esperion's (ESPR) regulatory applications for bempedoic acid monotherapy and combo seeking approval for lowering LDL-C are under review. However, absence of adequate funds may jeopardize the launch.
Nearly 90 percent survival for patients who received REGN-EB3 treatment earlier in the course of their disease; 66.5 percent survival among all patients who received REGN-EB3
Vyriad Inc., a company that creates cancer-killing viruses, has raised $24.4 million as part of a planned $37.8 million Series B financing round.
Regeneron Pharmaceuticals, Inc. (REGN) today announced that George D. Yancopoulos, M.D., Ph.D., Co-Founder, President and Chief Scientific Officer, was awarded Columbia College's Alexander Hamilton Medal, the highest honor awarded to a member of the Columbia College community for distinguished service and accomplishment in any field of endeavor.
The Zacks Analyst Blog Highlights: Alexion Pharmaceuticals, Vertex Pharmaceuticals, Incyte and Regeneron Pharmaceuticals
Zacks.com featured highlights include: Brinker International, Sonic Automotive, Fulgent Genetics, Hewlett Packard and Regeneron Pharmaceuticals
Drug giant Roche is buying another Boston area biotech startup, this time paying $390 million upfront for the company’s treatments for tissue scarring.